FDA Approved: LACOSAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lacosamide from ANI Pharmaceuticals, Inc., under ANDA 216151.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

SUPPL AP for LACOSAMIDE (LACOSAMIDE)